Urolithin A Safe in Middle-Aged Adults with Obesity, But Fails to Improve Endothelial Function: JAMA

Coverage, in order

1. 1d ago
   
   Medical Dialogues India obscure peer-reviewed

   Urolithin A Safe in Middle-Aged Adults with Obesity, But Fails to Improve Endothelial Function: JAMA

   USA: A new study showed that four weeks of Urolithin A (UA) supplementation did not yield a statistically significant improvement in peripheral endothelial function among middle-aged adults with obesity . Further, Urolithin A supplementation was well tolerated, with no notable safety concerns…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.